10/08/2026
๐ ๐ ๐ป๐ฒ๐ ๐๐ฎ๐ ๐๐ผ ๐ฝ๐ฟ๐ผ๐๐ฒ๐ฐ๐ ๐๐ผ๐๐ฟ๐๐ฒ๐น๐ณ ๐ณ๐ฟ๐ผ๐บ ๐๐๐ฉ ๐ถ๐ ๐ป๐ผ๐ ๐ฎ๐๐ฎ๐ถ๐น๐ฎ๐ฏ๐น๐ฒ ๐ฎ๐ ๐ช๐ถ๐๐ธ๐ผ๐ฝ๐ฝ๐ฒ๐ป ๐๐น๐ถ๐ป๐ถ๐ฐ.
The Lenacapavir PrEP injection is a long-acting HIV prevention option designed for people at increased risk of HIV infection.
๐ช๐ต๐ผ ๐ฐ๐ฎ๐ป ๐ฎ๐ฐ๐ฐ๐ฒ๐๐ ๐ถ๐?
โข Pregnant and postnatal women (ANC/PNC)
โข Adolescent Girls and Young Women (AGYW) aged 15โ24 years
โข Key populations (MSM, PWID, FSW)
โข Individuals who are HIV-negative and have an HIV-positive sexual partner
โข Individuals currently using oral PrEP who would like to switch to Lenacapavir
๐๐ง๐ฎ๐ฝ ๐ฝ๐น๐ฎ๐ ๐๐ผ ๐น๐ฒ๐ฎ๐ฟ๐ป ๐บ๐ผ๐ฟ๐ฒ.